Correcting underlying hormonal imbalances often accelerates weight loss and improves overall well-being
2005;93 Suppl 1:S157S61
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist, leads to superior body weight loss in rodent models. Science Translational Medicine , 10(451), eaat8712
Semaglutide and Wegovy mimic a hormone that regulates appetite and blood sugar, while Zepbound targets two hormones for potentially greater weight loss
One to two refeed days per week at maintenance calories can improve long-term progress compared to continuous restriction
Although high concentrations (500 mol/l) of metformin were required to observe AMPK activation after brief (1 h) treatment of cells, significant effects were observed after incubation for much longer periods with just 20 mol/l metformin, more compatible with concentrations of the drug found in the portal vein